Takeda raises $7.5 billion to help fund Shire purchase

8 June 2018
mergers-acquisitions-big

Japan’s Takeda Pharmaceutical (TSE: 4502) has managed to raise up to $7.5 billion in a term loan credit agreement from financial institutions including JP Morgan Chase, Sumitomo Mitsui Banking Corporation, MUFG Bank, and others. Most of the money was provided by Japanese companies.

The money is intended to cover part of the firm’s proposed $62 billion acquisition of London-listed rare disease specialist Shire (LSE: SHP).

Chief executive Christophe Weber, who has faced criticism from a minority of shareholders concerned about the size of the purchase, has previously said he believed Takeda could borrow money to fund the deal while maintaining dividends and without diluting shares.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical